| Texto completo | |
| Autor(es): |
Vendrame, Felipe
[1]
;
Olops, Leticia
[1]
;
Saad, Sara Teresinha Olalla
[1]
;
Costa, Fernando Ferreira
[1]
;
Fertrin, Kleber Yotsumoto
[2, 1]
Número total de Autores: 5
|
| Afiliação do(s) autor(es): | [1] Univ Estadual Campinas, UNICAMP, Hematol & Hemotherapy Ctr, Campinas, SP - Brazil
[2] Univ Washington, Div Hematol, Seattle, WA 98195 - USA
Número total de Afiliações: 2
|
| Tipo de documento: | Artigo Científico |
| Fonte: | JOURNAL OF CLINICAL LIPIDOLOGY; v. 12, n. 6, p. 1532-1538, DEC 2018. |
| Citações Web of Science: | 4 |
| Resumo | |
BACKGROUND: High blood cholesterol is associated with atherogenesis and endothelial dysfunction. The latter is present in hemolytic diseases, such as sickle cell anemia, whose carriers have hypocholesterolemia and low incidence of coronary artery disease. OBJECTIVE: We aimed to characterize cholesterol fractions in patients with sickle cell disease and explore the relationship among lipoproteins, varying degrees of hemolysis, and its biomarkers. METHODS: We recruited 37 healthy individuals, 39 with hemoglobin SC disease, and 40 with sickle cell anemia and quantified cholesterol fractions, heme resulting from hemoglobin breakdown, and its main scavenger protein hemopexin. RESULTS: Hypocholesterolemia was most significant in patients with sickle cell anemia, and cholesterol levels correlated positively with hemopexin. Nevertheless, patients still had higher relative low-density lipoprotein (LDL) oxidation than healthy subjects. Analysis of lipoproteins isolated by density ultracentrifugation showed that the LDL fraction contained higher concentrations of heme than the high-density lipoprotein (HDL) fraction, whereas HDL contained more hemopexin than LDL, albeit greatly reduced in patients. CONCLUSION: Our findings show that the abnormally low lipoprotein levels in sickle cell anemia correlate with hemolysis markers, particularly with hemopexin concentrations, along with significant reduction of this heme scavenger in HDL fractions. This may suggest an important role for HDL in the defense against heme-induced endothelial dysfunction in hemolytic diseases. (C) 2018 National Lipid Association. All rights reserved. (AU) | |
| Processo FAPESP: | 14/00984-3 - Doenças dos glóbulos vermelhos: fisiopatologia e novas abordagens terapêuticas |
| Beneficiário: | Fernando Ferreira Costa |
| Modalidade de apoio: | Auxílio à Pesquisa - Temático |